H Lundbeck A/S Liabilities 2024

H Lundbeck A/S Aktienanalyse

What does H Lundbeck A/S do?

H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing H Lundbeck A/S's Liabilities

H Lundbeck A/S's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating H Lundbeck A/S's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing H Lundbeck A/S's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

H Lundbeck A/S's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in H Lundbeck A/S’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about H Lundbeck A/S stock

What is the level of liabilities of H Lundbeck A/S this year?

H Lundbeck A/S has a debt balance of 16.37 B DKK this year.

What were the liabilities of H Lundbeck A/S compared to the previous year?

The liabilities of H Lundbeck A/S have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of H Lundbeck A/S?

High liabilities can pose a risk for investors of H Lundbeck A/S, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in H Lundbeck A/S?

Low liabilities mean that H Lundbeck A/S has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of H Lundbeck A/S affect the company?

An increase in liabilities of H Lundbeck A/S can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of H Lundbeck A/S affect the company?

A decrease in the liabilities of H Lundbeck A/S can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of H Lundbeck A/S?

Some factors that can influence the liabilities of H Lundbeck A/S include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of H Lundbeck A/S so important for investors?

The liabilities of H Lundbeck A/S are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can H Lundbeck A/S take to modify the liabilities?

To change its liabilities, H Lundbeck A/S can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does H Lundbeck A/S pay?

Over the past 12 months, H Lundbeck A/S paid a dividend of 2.5 DKK . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, H Lundbeck A/S is expected to pay a dividend of 15.45 DKK.

What is the dividend yield of H Lundbeck A/S?

The current dividend yield of H Lundbeck A/S is 1.45 %.

When does H Lundbeck A/S pay dividends?

H Lundbeck A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of H Lundbeck A/S?

H Lundbeck A/S paid dividends every year for the past 10 years.

What is the dividend of H Lundbeck A/S?

For the upcoming 12 months, dividends amounting to 15.45 DKK are expected. This corresponds to a dividend yield of 8.94 %.

In which sector is H Lundbeck A/S located?

H Lundbeck A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von H Lundbeck A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of H Lundbeck A/S from 3/28/2022 amounting to 2 DKK, you needed to have the stock in your portfolio before the ex-date on 3/24/2022.

When did H Lundbeck A/S pay the last dividend?

The last dividend was paid out on 3/28/2022.

What was the dividend of H Lundbeck A/S in the year 2023?

In the year 2023, H Lundbeck A/S distributed 2 DKK as dividends.

In which currency does H Lundbeck A/S pay out the dividend?

The dividends of H Lundbeck A/S are distributed in DKK.